PARK7 and myotonic dystrophy type 1: We also validated our method by analyzing a representative group of eye images from six independent published and unpublished studies, including genetic screens for modifiers of tau-induced neurotoxicity (Ambegaokar and Jackson 2011), interactors of dFoxO (Kanao et al. 2010), interactors of DJ-1, a peptide library screen for Drosophila model of myotonic dystrophy type 1 (DM1) (Garcia-Lopez et al. 2011), and a genetic screen for interactors of Egfr (Mardon et al. 1994).